The FDA has recently approved a revolutionary device called the “bionic pancreas” for diabetics. This innovative device takes the burden of constantly tracking carb intake off users, allowing them to focus on other things in their lives. With the bionic pancreas, users can simply input the size of their next meal, and an AI algorithm determines the precise amount of insulin needed to maintain stable blood sugar levels.
For 15-year-old Mia Campos, living with type 1 diabetes for five years, this new technology has been life-changing. Diagnosed with diabetes during a gymnastics competition when she experienced symptoms like excessive thirst and frequent urination, Mia was fitted with a traditional insulin pump which required constant programming and often experienced glitches. However, her pediatric endocrinologist recommended the bionic pancreas, which has now been cleared by the FDA for commercial use. Clipped to her jeans and using AI software to tailor insulin delivery to her glucose levels, Mia is thrilled with the benefits of this device.
The iLet device is approved for use in individuals aged six and up and requires just one input regarding the size of the user’s next meal. The device then learns the user’s biorhythms and delivers insulin accordingly, keeping blood sugar levels stable. Dr. Lynch, Mia’s pediatric endocrinologist emphasizes that diet and exercise are still critical components of managing blood sugar levels. Mia believes that this new technology will greatly benefit individuals, particularly children who have busy lives and struggle to manually track their carb intake.
The bionic pancreus uses a plastic infusion set attached to the body to communicate with sensors and deliver insulin as needed. With this innovative device, diabetics can now focus on other aspects of their lives without worrying about constantly monitoring their carb intake and insulin levels.
